Please sign in to follow a disease.
HIIT may boost heart health after stroke, new trial shows
NCT ID NCT06132516
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether high-intensity interval training (HIIT) on a stationary bike can improve heart rate variability—a key sign of recovery—in people who recently had a stroke. Fifty patients within three months of their first stroke will either do HIIT or low-intensity group exercises for six weeks. Researchers hope HIIT can become a standard part of stroke rehab to help patients regain heart and nervous system function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2024
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * first-ever hemispheric stroke, with consistent clinical and neuroimaging signs * \<3 month * NIHSS \<20 in acute care Exclusion Criteria: * age\<18 years-old * diabetes mellitus complicated by neuropathy or autonomic dysfunction; or any other concomitant nervous system, cardiac or pulmonary disease possibly affecting the autonomic nervous system ie: * myocardial infarction\< 6 months, * myocardial dysfunction as severe dilated or hypertrophic cardiomyopathy, class 3 and 4 heart failure, * severe conduction abnormalities and arrhythmias, including chronic atrial fibrillation, * mechanical ventilation, * beta-blockers with no alternative options, pharmacological mandatory treatment possibly affecting the autonomic nervous system and HRV. * severe cognitive impairment inconsistent with free, informed and written consent or questionnaire filling
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr BARTHOLOMEI MN
Hyères, PACA, 83418, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Zapping the spine while wearing a robotic ankle: a new way to help kids walk?
- Can a nurse and a neighbor help tame chronic disease?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Two ways to catch a hidden heart rhythm after stroke